Awakn Life Sciences (OTC:AWKNF), a clinical-stage biotechnology company specializing in the development of ketamine-assisted treatments for addiction, has entered into a global licensing agreement ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback